Partner Alexander Chae is quoted in an article published in Of Counsel’s Diversity Report section, “Firms Make Strides but Still Not Achieving Sufficient Progress.” In the article, Chae covers various topics that impact law firm diversity, such as minority retention, comparisons to corporate America and the tendency of millennials to change jobs.
He says that diversity is essential because it creates a more holistic workforce, benefitting both law firms and their clients.
“The people who are purchasing our services are not just white males,” said Chae. “They’re comforted to know that we have people who may come from similar backgrounds, and have similar experiences and perspectives. It’s an absolute necessity to have that. It’s not an option: It’s a must.”
He says that diversity is essential because it creates a more holistic workforce, benefitting both law firms and their clients.
“The people who are purchasing our services are not just white males,” said Chae. “They’re comforted to know that we have people who may come from similar backgrounds, and have similar experiences and perspectives. It’s an absolute necessity to have that. It’s not an option: It’s a must.”
People
Related News
10 October 2024
In the News
Christopher King Highlights M&A Due Diligence Considerations
Foley & Lardner LLP partner Christopher King's comments on M&A due diligence at the Association of Corporate Counsel's annual meeting were highlighted in the Legal Dive article, "Can this marriage work? Legal tips for corporate M&A."
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."